会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Benzodiazepine derivatives and production thereof
    • 苯并二氮杂衍生物及其制备
    • US3864330A
    • 1975-02-04
    • US28201272
    • 1972-08-21
    • SUMITOMO CHEMICAL CO
    • KATSUBE JUNKITAKASHIMA YOSHINORIHIROHASHI TOSHIYUKIISHIZUMI KIKUOAKATSU MITSUHIROMORI KAZUOKATSUKI ISAOKUME YOSHIHARUSATO HIROMIINABA SHIGEHOYAMAMOTO HISAO
    • C07D243/24C07D243/26C07D53/06
    • C07D243/24
    • The present invention relates to 1,4-benzodiazepine derivatives represented by the general formula:

      D R A W I N G
      (WHEREIN EACH OF R6 and R7 represents hydrogen, C1 - C6 alkyl, C2 - C6 alkenyl or alkynyl, C3 - C6 cycloalkyl- C1 - C4 alkyl, substituted or unsubstituted hydroxy, substituted or unsubstituted hydroxy- C1 - C4 alkyl, or substituted or unsubstituted amino, or substituted or unsubstituted amino- C1 - C4 alkyl group), -CN, -R8 (wherein R8 represents C1 - C10 alkyl, or C1 - C4 alkoxyC1- C4 alkyl group), -OCH2-R9 (wherein R9 represents hydrogen, C1 - C6 alkyl, C2 - C6 alkenyl or alkynyl, phenyl, or phenyl- C1 - C4 alkyl group), OR -C*C-R10 (wherein R10 represents hydrogen, or C1 - C6 alkyl groups which may be substituted by a secondary amino group or by a substituted or unsubstituted hydroxy group).

      WHEREIN R1 is a member selected from the group consisting of hydrogen, halogen, nitro, and trifluoromethyl group, R2 represents a member selected from the group consisting of hydrogen, C1 - C6 alkyl, C2 - C6 alkenyl or alkynyl, C3 - C6 cycloalkyl- C1 - C4 alkyl, and substituted or unsubstituted hydroxy- C1 - C4 alkyl group, R3 represents alkyl group having 1 - 4 carbon atoms, EACH OF R4 and R5 represents a member selected from the group consisting of hydrogen, halogen, C1 - C4 alkyl, and trifluoromethyl group, AND Z represents
    • 本发明涉及由以下通式表示的1,4-苯并二氮杂衍生物:其中R 1为选自氢,卤素,硝基和三氟甲基的成员,R 2表示选自氢, C 1 -C 6烷基,C 2 -C 6烯基或炔基,C 3 -C 6环烷基-C 1 -C 4烷基和取代或未取代的羟基-C 1 -C 4烷基,R 3表示具有1-4个碳原子的烷基,每个R 4和R 5 表示选自氢,卤素,C 1 -C 4烷基和三氟甲基的成员,Z表示(其中R 6和R 7各自表示氢,C 1 -C 6烷基,C 2 -C 6烯基或炔基,C 3 -C 6 环烷基-C 1 -C 4烷基,取代或未取代的羟基,取代或未取代的羟基-C 1 -C 4烷基或取代或未取代的氨基,或取代或未取代的氨基-C 1 -C 4烷基),-CN,-R 8(其中R 8表示 C1-C10烷基,或 C 1 -C 4烷氧基-C 1 -C 4烷基),-OCH 2 -R 9(其中R 9表示氢,C 1 -C 6烷基,C 2 -C 6烯基或炔基,苯基或苯基-C 1 -C 4烷基),OR -C 3 C-R 10(其中R 10表示氢,或可被仲氨基取代或被取代或未取代的羟基取代的C 1 -C 6烷基)。
    • 2. 发明授权
    • Benzodiazepine derivatives and preparation thereof
    • 苯并二氮杂衍生物及其制备
    • US3906003A
    • 1975-09-16
    • US19469071
    • 1971-11-01
    • SUMITOMO CHEMICAL CO
    • AKATSU MITSUHIROKUME YOSHIHARUHIROHASHI TOSHIYUKIINABA SHIGEHOYAMAMOTO HISAOSATO HIROMI
    • C07D243/24C07D243/26C07D243/28C07D243/30C07D405/06C07D53/06
    • C07D243/24C07D243/26C07D243/28C07D243/30C07D243/36C07D405/06
    • Novel benzodiazepines having valuable pharmaceutical properties, which are represented by the formula

      WHEREIN R1 represents hydrogen, halogen, nitro or trifluoromethyl; R2 represents pyridyl, cyclohexenyl or a group of the formula

      (IN WHICH R7 and R8 each represent hydrogen, halogen, lower alkyl or trifluoromethyl); R3 represents hydrogen, lower alkyl, aryl or aralkyl; R4 represents hydroxy, lower alkoxy or acyloxy; R5 represents hydrogen, hydroxy or acyloxy, provided that R4 and R5 are not hydroxy group simultaneously; or R4 and R5 together may be joined to form a group of the formula,

      (in which R9 and R10 each represents hydrogen, lower alkyl, lower alkenyl, aryl, aralkyl, cycloalkyl or cycloalkylalkyl; R11 represents hydrogen, lower alkyl or halogen; and B represents oxygen or sulfur); R6 represents hydrogen, cyano, acyloxy, alkoxycarbonyl or a group of the formula,

      (in which R12 and R13 each represent hydrogen or lower alkyl, or R12 and R13 may form an optionally substituted 5- or 6-membered heterocyclic ring together with the adjacent nitrogen atom, and said heterocyclic ring may further contain one or more hetero atom; R14 represents hydrogen, acyl, lower alkyl, lower alkenyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, polyhaloalkyl or cyanoalkyl; A represents oxygen, sulfur, sulfinyl or sulfonyl; and p represents 0 or 1); l represents 0 or 1; m represents 0, 1, 2 or 3; and n represents 1, 2, 3 or 4.
    • 具有有价值药物性质的新型苯并二氮杂由式R4R5表示| CnH2n-CH-CH-CmH2m-R6 | O并行N-C(I)角度CH-R3 C = N |&Darr&R2(O)l 其中R1表示氢,卤素,硝基或三氟甲基; R 2表示吡啶基,环己烯基或式[基团,其中R 7和R 8各自表示氢,卤素,低级烷基或三氟甲基]; R3表示氢,低级烷基,芳基或芳烷基; R4表示羟基,低级烷氧基或酰氧基; R5表示氢,羟基或酰氧基,条件是R4和R5不同时为羟基; 或R 4和R 5一起可以连接形成下式基团:R9R10 R9R10 || ANGLE C ANGLE CH-CH || OO,OO || || B或PARALLEL CO角度角OO角度角O [其中R9和 R 10各自表示氢,低级烷基,低级烯基,芳基,芳烷基,环烷基或环烷基烷基; R 11表示氢,低级烷基或卤素; B代表氧或硫]; R 12表示氢,氰基,酰氧基,烷氧基羰基或下式基团:R 12 R 12 -N ANGLE,-CO-N ANGLE或 - (A)p -R 14 R 13 R 13 [其中R 12和R 13各自表示氢或低级烷基, 或R 12和R 13可以与相邻的氮原子一起形成任选取代的5元或6元杂环,并且所述杂环可以进一步含有一个或多个杂原子; R14代表氢,酰基,低级烷基,低级烯基,环烷基,环烷基烷基,芳基,芳烷基,多卤代烷基或氰基烷基; A代表氧,硫,亚磺酰基或磺酰基; 和p代表0或1]; l表示0或1; m表示0,1,2或3; n表示1,2,3或4。
    • 6. 发明专利
    • FI54312C
    • 1978-11-10
    • FI136973
    • 1973-04-27
    • SUMITOMO CHEMICAL CO
    • HIROHSHI TOSHIYUKISATO HIROMIINABA SHIGEHOYAMAMOTO HISAO
    • C07D333/36C07D333/66C07D495/04
    • 1397501 Thienopyrimidines SUMITOMO CHEMICAL CO Ltd 7 May 1973 [9 May 1972 3 July 1972 26 July 1972 9 Dec 1972 14 Dec 1972] 21647/73 Heading C2C Novel compounds (I), (II), (III) and (IV) wherein D is a hydrogen atom, an alkyl group or a group of the formula R 1 is a hydrogen atom, an alkyl group, an alkoxy group, a nitro group, a trifluoromethyl group, an alkylthio group, an alkylsulfonyl group, a halogen atom or R 1 and R 2 may together from a trimethylene, tetramethylene or pentamethylene group; R 2 and R 3 are independently a hydrogen atom, an alkyl group, an alkoxy group, a nitro group, a trifluoromethyl group, an alkylthio group, an alkylsulfonyl group or a halogen atom; R is a hydrogen atom, an alkyl group, an alkenyl group, an aralkyl group, an alkoxyalkyl group, a cycloalkylalkyl group, a haloalkyl group, an alkylthioalkyl group, an alkoxycarbonylalkyl group, an alkanoyloxyalkyl group, or a group of the formula (wherein A is an alkylene group ; R 4 , R 5 , R 6 and R 7 are independently a hydrogen atom or an alkyl group, which may form together with the adjacent nitrogen atom an unsubstituted or optionally substituted 5- or 6-membered heterocyclic ring, which may further contain a hetero atom, are made by standard methods, especially by cyclizing compounds (IV) (W is oxygen or imino) or by halogenation, nitration and alkylation of appropriate thieno-pyrimidines; (IV) are themselves prepared by hydrolysing the corresponding N-methylacetamido-compounds (obtained from the corresponding acetamidocompounds). Pharmaceutical preparations having antiinflammatory, analgesic, antiviral, uricosuric, diuretic and CNS actions contain (I), (II) and/or (III) as active ingredient; administration is orally or parenterally.
    • 7. 发明专利
    • NO138599B
    • 1978-06-26
    • NO190373
    • 1973-05-08
    • SUMITOMO CHEMICAL CO
    • HIROHASHI TOSHIYUKISATO HIROMIINABA SHIGEHOYAMAMOTO HISAO
    • C07D333/36C07D333/66C07D495/04
    • 1397501 Thienopyrimidines SUMITOMO CHEMICAL CO Ltd 7 May 1973 [9 May 1972 3 July 1972 26 July 1972 9 Dec 1972 14 Dec 1972] 21647/73 Heading C2C Novel compounds (I), (II), (III) and (IV) wherein D is a hydrogen atom, an alkyl group or a group of the formula R 1 is a hydrogen atom, an alkyl group, an alkoxy group, a nitro group, a trifluoromethyl group, an alkylthio group, an alkylsulfonyl group, a halogen atom or R 1 and R 2 may together from a trimethylene, tetramethylene or pentamethylene group; R 2 and R 3 are independently a hydrogen atom, an alkyl group, an alkoxy group, a nitro group, a trifluoromethyl group, an alkylthio group, an alkylsulfonyl group or a halogen atom; R is a hydrogen atom, an alkyl group, an alkenyl group, an aralkyl group, an alkoxyalkyl group, a cycloalkylalkyl group, a haloalkyl group, an alkylthioalkyl group, an alkoxycarbonylalkyl group, an alkanoyloxyalkyl group, or a group of the formula (wherein A is an alkylene group ; R 4 , R 5 , R 6 and R 7 are independently a hydrogen atom or an alkyl group, which may form together with the adjacent nitrogen atom an unsubstituted or optionally substituted 5- or 6-membered heterocyclic ring, which may further contain a hetero atom, are made by standard methods, especially by cyclizing compounds (IV) (W is oxygen or imino) or by halogenation, nitration and alkylation of appropriate thieno-pyrimidines; (IV) are themselves prepared by hydrolysing the corresponding N-methylacetamido-compounds (obtained from the corresponding acetamidocompounds). Pharmaceutical preparations having antiinflammatory, analgesic, antiviral, uricosuric, diuretic and CNS actions contain (I), (II) and/or (III) as active ingredient; administration is orally or parenterally.
    • 8. 发明专利
    • BENZODIAZEPINE DERIVATIVES AND PREPARATION THEREOF
    • CA1010033A
    • 1977-05-10
    • CA125391
    • 1971-10-18
    • SUMITOMO CHEMICAL CO
    • AKATSU MITSUHIROKUME YOSHIHARUHIROHASHI TOSHIYUKIISHIZUMI KIKUOYAMAMOTO MICHIHIROMARUYAMA ISAMUMORI KAZUOIZUMI TAKAHIROINABA SHIGEHOYAMAMOTO HISAOSATO HIROMI
    • C07D243/24C07D243/26C07D243/28C07D243/30C07D405/06
    • Novel benzodiazepines having valuable pharmaceutical properties, which are represented by the formula R4R5 ¦¦ CnH2n-CH-CH-CmH2m-R6 ¦O PARALLEL N--C (I) ANGLE ANGLE CH-R3 C=N ¦ &darr& R2(O)l WHEREIN R1 represents hydrogen, halogen, nitro or trifluoromethyl; R2 represents pyridyl, cyclohexenyl or a group of the formula [IN WHICH R7 and R8 each represent hydrogen, halogen, lower alkyl or trifluoromethyl]; R3 represents hydrogen, lower alkyl, aryl or aralkyl; R4 represents hydroxy, lower alkoxy or acyloxy; R5 represents hydrogen, hydroxy or acyloxy, provided that R4 and R5 are not hydroxy group simultaneously; or R4 and R5 together may be joined to form a group of the formula, R9R10 R9R10 ¦¦ ANGLE C ANGLE CH-CH ¦¦ OO, OO ¦¦ ¦¦ B or PARALLEL C O ANGLE ANGLE O O ANGLE ANGLE O [in which R9 and R10 each represents hydrogen, lower alkyl, lower alkenyl, aryl, aralkyl, cycloalkyl or cycloalkylalkyl; R11 represents hydrogen, lower alkyl or halogen; and B represents oxygen or sulfur]; R6 represents hydrogen, cyano, acyloxy, alkoxycarbonyl or a group of the formula, R12 R12 -N ANGLE , -CO-N ANGLE or-(A)p-R14 R13 R13 [in which R12 and R13 each represent hydrogen or lower alkyl, or R12 and R13 may form an optionally substituted 5- or 6-membered heterocyclic ring together with the adjacent nitrogen atom, and said heterocyclic ring may further contain one or more hetero atom; R14 represents hydrogen, acyl, lower alkyl, lower alkenyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, polyhaloalkyl or cyanoalkyl; A represents oxygen, sulfur, sulfinyl or sulfonyl; and p represents 0 or 1]; l represents 0 or 1; m represents 0, 1, 2 or 3; and n represents 1, 2, 3 or 4.